Dr Sean J Murphy, DPT in West Winfield, NY - Physical Therapist

Dr Sean J Murphy, DPT is a Physical Therapist based in West Winfield, New York. Dr Sean J Murphy is licensed to practice in New York (license number 029876) and his current practice location is 243 Water St., West Winfield, New York. He can be reached at his office (for appointments etc.) via phone at (315) 822-3094.

NPI number for Dr Sean J Murphy is 1578995486 and his current mailing address is 243 Water St., West Winfield, New York. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1578995486.

Contact Information

	Dr Sean J Murphy, DPT
	243 Water St., West Winfield, NY 13491
	(315) 822-3094
	Not Available

Healthcare Provider's Profile

Full Name	Dr Sean J Murphy
Gender	Male
Speciality	Physical Therapist
Location	243 Water St., West Winfield, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1578995486
Provider Enumeration Date: 08/01/2013
Last Update Date: 08/01/2013

Medical Identifiers

Medical identifiers for Dr Sean J Murphy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578995486	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	029876 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Sean J Murphy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Sean J Murphy, DPT 243 Water St., West Winfield, NY 13491 Ph: (315) 822-3094	Dr Sean J Murphy, DPT 243 Water St., West Winfield, NY 13491 Ph: (315) 822-3094

News Archive

Spectrum Pharmaceuticals to submit additional data for FUSILEV sNDA

Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has met with the FDA regarding it's supplemental New Drug Application (sNDA) for FUSILEV® (levoleucovorin) for injection for the treatment of patients with advanced metastatic colorectal cancer. In October 2009, the FDA issued a Complete Response letter regarding its sNDA for FUSILEV.

Nouveau Life explores line of specialty supplements for seniors

Nouveau Life Pharmaceuticals, Inc., a provider of quality all-natural dietary supplements, announced today that the Company is exploring a line of specialty supplements for seniors.

NIH awards VistaGen and NuPotential $500,000 grant to advance iPS stem cell technology

VistaGen Therapeutics, Inc. and NuPotential, Inc. today announced that the National Heart, Lung and Blood Institute of the U.S. National Institutes of Health (NIH) has awarded to the companies a grant of approximately $500,000 to accelerate development of novel and safer approaches to generate patient-specific induced pluripotent stem (iPS) cells for regenerative medicine, drug discovery and drug rescue.

Burkert's new cartridge valve shows uncompromising reliability and above-average service life

Due to the increasing importance of space considerations, fluid performance and energy saving potentials, customized solutions are constantly becoming more complex, accompanied by higher component requirements.

Dr Sean J Murphy, DPT - Physical Therapist in West Winfield, NY